Practice
Managing thyroid disease in women planning pregnancy
Jennifer Yamamoto and Lois E. Donovan
CMAJ July 17, 2017 189 (28) E940; DOI: https://doi.org/10.1503/cmaj.170021
Jennifer Yamamoto
Department of Medicine (Yamamoto, Donovan), Division of Endocrinology and Metabolism; Department of Obstetrics and Gynecology (Donovan), University of Calgary, Calgary, Alta.
MDLois E. Donovan
Department of Medicine (Yamamoto, Donovan), Division of Endocrinology and Metabolism; Department of Obstetrics and Gynecology (Donovan), University of Calgary, Calgary, Alta.
MDRelated Articles
- No related articles found.
In this issue
Article tools
Respond to this article
Managing thyroid disease in women planning pregnancy
Jennifer Yamamoto, Lois E. Donovan
CMAJ Jul 2017, 189 (28) E940; DOI: 10.1503/cmaj.170021
Jump to section
- Article
- Women with pre-conception hypothyroidism often require increased levothyroxine once they are pregnant
- Women should avoid ingesting levothyroxine with iron- or calcium-containing supplements
- Rates of conception and live birth are not likely influenced by minor thyroid dysfunction4
- Women with active Graves disease or toxic adenoma should delay pregnancy until normal thyroid function is established
- Propylthiouracil is preferred for antithyroid drug treatment before conception
- Acknowledgements
- Footnotes
- References
- Figures & Tables
- Responses
- Metrics
Related Articles
- No related articles found.
Cited By...
- No citing articles found.